array:21 [
  "pii" => "X0873215915188377"
  "issn" => "08732159"
  "doi" => "10.1016/j.rppnen.2015.04.002"
  "estado" => "S300"
  "fechaPublicacion" => "2015-05-01"
  "documento" => "article"
  "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
  "subdocumento" => "fla"
  "cita" => "Rev Port Pneumol. 2015;21:111-2"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 3995
    "formatos" => array:3 [
      "EPUB" => 236
      "HTML" => 2654
      "PDF" => 1105
    ]
  ]
  "itemSiguiente" => array:16 [
    "pii" => "X0873215915188385"
    "issn" => "08732159"
    "doi" => "10.1016/j.rppnen.2014.09.009"
    "estado" => "S300"
    "fechaPublicacion" => "2015-05-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Rev Port Pneumol. 2015;21:113-25"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 5455
      "formatos" => array:3 [
        "EPUB" => 224
        "HTML" => 4239
        "PDF" => 992
      ]
    ]
    "en" => array:11 [
      "idiomaDefecto" => true
      "titulo" => "Lung adenocarcinoma: Sustained subtyping with immunohistochemistry and EGFR, HER2 and KRAS mutational status"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "113"
          "paginaFinal" => "125"
        ]
      ]
      "contieneResumen" => array:1 [
        "en" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig1"
          "etiqueta" => "Figure 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "copyright" => "Elsevier España"
          "descripcion" => array:1 [
            "en" => "Case 21: 2+ CK20 expression&#59; acinar pattern. 200×."
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Vitor Sousa, Carolina Rodrigues, Maria Silva, Ana Maria Alarcão, Lina Carvalho"
          "autores" => array:5 [
            0 => array:2 [
              "nombre" => "Vitor"
              "apellidos" => "Sousa"
            ]
            1 => array:2 [
              "nombre" => "Carolina"
              "apellidos" => "Rodrigues"
            ]
            2 => array:2 [
              "nombre" => "Maria"
              "apellidos" => "Silva"
            ]
            3 => array:2 [
              "nombre" => "Ana Maria"
              "apellidos" => "Alarcão"
            ]
            4 => array:2 [
              "nombre" => "Lina"
              "apellidos" => "Carvalho"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0873215915188385?idApp=UINPBA00004E"
    "url" => "/08732159/0000002100000003/v0_201604141146/X0873215915188385/v0_201604141146/en/main.assets"
  ]
  "itemAnterior" => array:16 [
    "pii" => "X0873215915188369"
    "issn" => "08732159"
    "doi" => "10.1016/j.rppnen.2015.04.001"
    "estado" => "S300"
    "fechaPublicacion" => "2015-05-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Rev Port Pneumol. 2015;21:109-10"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 3162
      "formatos" => array:3 [
        "EPUB" => 238
        "HTML" => 1987
        "PDF" => 937
      ]
    ]
    "en" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "Routine characterization of biomarkers in non-small cell lung carcinoma: how much is enough?"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "109"
          "paginaFinal" => "110"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "José Carlos Machado"
          "autores" => array:1 [
            0 => array:2 [
              "nombre" => "José Carlos"
              "apellidos" => "Machado"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0873215915188369?idApp=UINPBA00004E"
    "url" => "/08732159/0000002100000003/v0_201604141146/X0873215915188369/v0_201604141146/en/main.assets"
  ]
  "asociados" => array:1 [
    0 => array:18 [
      "pii" => "S2173511515000226"
      "issn" => "21735115"
      "doi" => "10.1016/j.rppnen.2014.07.004"
      "estado" => "S300"
      "fechaPublicacion" => "2015-05-01"
      "aid" => "1026"
      "copyright" => "Sociedade Portuguesa de Pneumologia"
      "documento" => "article"
      "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
      "subdocumento" => "sco"
      "cita" => "Rev Port Pneumol. 2015;21:151-6"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 1935
        "formatos" => array:3 [
          "EPUB" => 253
          "HTML" => 1166
          "PDF" => 516
        ]
      ]
      "en" => array:12 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Brief Communication</span>"
        "titulo" => "Real-life efficacy and safety of omalizumab in Portuguese patients with persistent uncontrolled asthma"
        "tienePdf" => "en"
        "tieneTextoCompleto" => "en"
        "tieneResumen" => "en"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "151"
            "paginaFinal" => "156"
          ]
        ]
        "contieneResumen" => array:1 [
          "en" => true
        ]
        "contieneTextoCompleto" => array:1 [
          "en" => true
        ]
        "contienePdf" => array:1 [
          "en" => true
        ]
        "resumenGrafico" => array:2 [
          "original" => 0
          "multimedia" => array:7 [
            "identificador" => "fig0005"
            "etiqueta" => "Figure 1"
            "tipo" => "MULTIMEDIAFIGURA"
            "mostrarFloat" => true
            "mostrarDisplay" => false
            "figura" => array:1 [
              0 => array:4 [
                "imagen" => "gr1.jpeg"
                "Alto" => 1765
                "Ancho" => 1667
                "Tamanyo" => 166595
              ]
            ]
            "descripcion" => array:1 [
              "en" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Analysis over the 24 months of treatment period&#46; &#40;a&#41; Effect on asthma control as measured by investigator assessment&#59; &#40;b&#41; effect on reduction in corticosteroid requirement&#46; Values are for the week before specified time points&#46;</p>"
            ]
          ]
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "M&#46; Pereira Barbosa, A&#46; Bugalho de Almeida, C&#46; Pereira, C&#46;-W&#46; Chen, P&#46; Georgiou, G&#46; Peachey"
            "autores" => array:7 [
              0 => array:2 [
                "nombre" => "M&#46;"
                "apellidos" => "Pereira Barbosa"
              ]
              1 => array:2 [
                "nombre" => "A&#46;"
                "apellidos" => "Bugalho de Almeida"
              ]
              2 => array:2 [
                "nombre" => "C&#46;"
                "apellidos" => "Pereira"
              ]
              3 => array:2 [
                "nombre" => "C&#46;-W&#46;"
                "apellidos" => "Chen"
              ]
              4 => array:2 [
                "nombre" => "P&#46;"
                "apellidos" => "Georgiou"
              ]
              5 => array:2 [
                "nombre" => "G&#46;"
                "apellidos" => "Peachey"
              ]
              6 => array:1 [
                "colaborador" => "on behalf of eXpeRience study group"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "en"
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173511515000226?idApp=UINPBA00004E"
      "url" => "/21735115/0000002100000003/v2_201505070217/S2173511515000226/v2_201505070217/en/main.assets"
    ]
  ]
  "en" => array:9 [
    "idiomaDefecto" => true
    "titulo" => "Omalizumab&#58; a treatment for severe asthma in real life&#63;"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "111"
        "paginaFinal" => "112"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Ana&#239;s Briquet, Pascal Chanez"
        "autores" => array:2 [
          0 => array:3 [
            "nombre" => "Ana&#239;s"
            "apellidos" => "Briquet"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "affa"
              ]
            ]
          ]
          1 => array:4 [
            "nombre" => "Pascal"
            "apellidos" => "Chanez"
            "email" => array:1 [
              0 => "pascal&#46;chanez&#64;univ-amu&#46;fr"
            ]
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "affa"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor1"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:3 [
            "entidad" => "Département des Maladies Respiratoires, AP&#x002D;HM, INSERM CNRS U 1067, UMR7733, Aix Marseille Université, Marseille, France"
            "etiqueta" => "<span class="elsevierStyleSup">a</span>"
            "identificador" => "affa"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor1"
            "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
            "correspondencia" => "Corresponding author. pascal.chanez@univ-amu.fr"
          ]
        ]
      ]
    ]
    "textoCompleto" => "<p class="elsevierStylePara">In 2015&#44; asthma remains an important health problem&#46; It is costly&#58; first as a chronic disorder it represents a significant burden for the patients and their relatives&#59; secondly due to management of disease including controller medications and what is required for acute exacerbations i&#46;e&#46;&#58; hospitalizations and days off work Overall&#44; while mortality has certainly decreased&#44; most of our current treatments are still primarily symptom based and do not alter with the natural history of the disease&#46; Meanwhile&#44; severe asthma remains a challenge&#44; as most patients with this type of asthma remain uncontrolled despite a real diagnosis&#44; a fair compliance and an important need of existing therapies with known side effects&#46;</p><p class="elsevierStylePara">Total IgE has been linked to asthma in epidemiological studies and was considered to be associated with an allergic phenotype of the disease&#46; More recently&#44; it has been shown to be a part of the high TH2 group of potential biomarkers&#44; such as eNO and blood eosinophils&#44; in predecting future risk including recurrent exacerbations&#46; IgE and IgE receptors play a part in the pathophysiology of asthma by activating various effector cells even in non- allergic situations&#46; Very recently an epigenome association with total IgE was reported&#44; and methylated genes encoding for eosinophil products were connected in a reproducible way&#46; The results were confirmed by isolated eosinophils from patients with high eosinophilia and asthma&#46; This type of study will certainly point towards new types of mechanisms&#44; which will allow a more personalized way to treat asthma&#46;<a href="&#35;bib1" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">1</span></a></p><p class="elsevierStylePara">Omalizumab has been shown in several well-performed studies to decrease the exacerbation rate in severe uncontrolled allergic asthma&#46;<a href="&#35;bib2" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">2</span></a> It has been used with success to treat mild asthma and allergic rhinitis and to prevent seasonal exacerbations in patients with a broad range of severity&#46;<a href="&#35;bib3" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">3</span></a> Randomized control studies are helpful to demonstrate the efficacy and safety of new drugs&#46; They are the bottom line of marketing in westernized countries&#46; They sustain the different guidelines&#44; but even though most of the recommendations are based on randomized control studies&#44; most of the patients with severe asthma are not qualified to enter RCP studies&#46;<a href="&#35;bib4" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">4</span></a> Therefore large pragmatic trials with real life conditions are currently more popular&#46; These trials will try to demonstrate efficiency and include a large numbers of patients&#46; They will enroll patients with less strict criteria&#44; closer a real clinical situation and allow a longitudinal follow-up with pertinent outcomes&#46;<a href="&#35;bib5" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">5</span></a><span class="elsevierStyleSup">&#44; </span><a href="&#35;bib6" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">6</span></a></p><p class="elsevierStylePara">In this issue of the journal&#44; taking advantage of the EXperience study&#44;<a href="&#35;bib7" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">7</span></a> our Portuguese colleagues have considered 62 patients from their own country to demonstrate an overall 60&#37; satisfaction with the treatment&#44; with a fair control of asthma including daily symptoms and exacerbations&#46; The treatment improves health related quality of life but has little impact on lung function&#46; This study describes an interesting observation and confirms the larger study from Grimaldi Bensoussa et al&#44; reporting the real improvement seen in the initial Innovate study&#46;<a href="&#35;bib8" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">8</span></a> The number of severe exacerbations and the need for oral corticosteroid upsurges were significantly decreased in this real life study of omalizumab treated patients as compared to the reference arm&#46; We can postulate that omalizumab is a well-established treatment in Europe for severe asthma&#46; It is advocated by the GINA guidelines and the ATS&#47;ERS task force on severe asthma&#44; however as a specific biotherapy it requires more investigation&#46;<a href="&#35;bib9" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">9</span></a> It would be worth knowing if we can confirm its efficacy in non-allergic severe asthma&#46;<a href="&#35;bib10" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">10</span></a> We are all fighting to improve antecipation of the response to the intervention&#46; At present&#44; we need specific biomarkers with an impact on future risk&#46; Last of all&#44; it is important to assess the potential for these interventions to go along with asthma remission&#44; but recent studies are not very encouraging&#46; Omalizumab is the first efficient and safe biotherapy for severe asthma with the potential to be used in this disease&#46; We should continue to question how it works and to report efficiency data from large real life cohort studies&#46;</p><p class="elsevierStylePara">Corresponding author&#46; pascal&#46;chanez&#64;univ-amu&#46;fr</p>"
    "pdfFichero" => "320v21n03a90418837pdf001.pdf"
    "tienePdf" => true
    "bibliografia" => array:2 [
      "titulo" => "Bibliography"
      "seccion" => array:1 [
        0 => array:1 [
          "bibliografiaReferencia" => array:10 [
            0 => array:3 [
              "identificador" => "bib1"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "An epigenome&#x002D;wide association study of total serum immunoglobulin E concentration. Nature. 2015. Feb 18. doi: 10.1038/nature14125. [Epub ahead of print]"
                  "contribucion" => array:1 [
                    0 => array:3 [
                      "titulo" => "An epigenome-wide association study of total serum immunoglobulin E concentration&#46;"
                      "idioma" => "en"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:7 [
                            0 => "Liang L"
                            1 => "Willis-Owen SAG"
                            2 => "Laprise C"
                            3 => "Wong KCC"
                            4 => "Davies GA"
                            5 => "Hudson TJ"
                            6 => "et-al&#46;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:2 [
                        "tituloSerie" => "Nature. "
                        "fecha" => "2015"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib2"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Omalizumab in asthma: an update on recent developments. J Allergy Clin Immunol Pract. 2014; 2:525&#x002D;36. e1"
                  "contribucion" => array:1 [
                    0 => array:3 [
                      "titulo" => "Omalizumab in asthma&#58; an update on recent developments&#46;"
                      "idioma" => "en"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:7 [
                            0 => "Humbert M"
                            1 => "Busse W"
                            2 => "Hanania NA"
                            3 => "Lowe PJ"
                            4 => "Canvin J"
                            5 => "Erpenbeck VJ"
                            6 => "et-al&#46;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jaip.2014.03.010"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Allergy Clin Immunol Pract. "
                        "fecha" => "2014"
                        "volumen" => "2"
                        "paginaInicial" => "525"
                        "paginaFinal" => "536"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25213045"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib3"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Randomized Trial of Omalizumab (Anti&#x002D;IgE) for Asthma in Inner&#x002D;City Children. N Engl J Med. 2011; 364:1005&#x002D;15."
                  "contribucion" => array:1 [
                    0 => array:3 [
                      "titulo" => "Randomized Trial of Omalizumab &#40;Anti-IgE&#41; for Asthma in Inner-City Children&#46;"
                      "idioma" => "en"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:7 [
                            0 => "Busse WW"
                            1 => "Morgan WJ"
                            2 => "Gergen PJ"
                            3 => "Mitchell HE"
                            4 => "Gern JE"
                            5 => "Liu AH"
                            6 => "et-al&#46;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMoa1009705"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med. "
                        "fecha" => "2011"
                        "volumen" => "364"
                        "paginaInicial" => "1005"
                        "paginaFinal" => "1015"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21410369"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib4"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "External Validity of Randomized Controlled Trials in Severe Asthma. AJRCCM. 2015. in press."
                  "contribucion" => array:1 [
                    0 => array:3 [
                      "titulo" => "External Validity of Randomized Controlled Trials in Severe Asthma&#46;"
                      "idioma" => "en"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "Pahus L"
                            1 => "Alagha K"
                            2 => "Sofalvi T"
                            3 => "et-al&#46;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:2 [
                        "tituloSerie" => "AJRCCM. "
                        "fecha" => "2015"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib5"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Can randomised trials inform clinical decisions about individual patients?. Lancet. 1999; 353:743&#x002D;6."
                  "contribucion" => array:1 [
                    0 => array:3 [
                      "titulo" => "Can randomised trials inform clinical decisions about individual patients&#63;&#46;"
                      "idioma" => "en"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "Mant D&#46;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S0140-6736(98)09102-8"
                      "Revista" => array:6 [
                        "tituloSerie" => "Lancet. "
                        "fecha" => "1999"
                        "volumen" => "353"
                        "paginaInicial" => "743"
                        "paginaFinal" => "746"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10073531"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib6"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Asthma treatment guidelines meet the real world. N Engl J Med. 2011; 364:1769&#x002D;70."
                  "contribucion" => array:1 [
                    0 => array:3 [
                      "titulo" => "Asthma treatment guidelines meet the real world&#46;"
                      "idioma" => "en"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "Dahl&#233;n S-E"
                            1 => "Dahl&#233;n B"
                            2 => "Drazen JM&#46;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMe1100937"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med. "
                        "fecha" => "2011"
                        "volumen" => "364"
                        "paginaInicial" => "1769"
                        "paginaFinal" => "1770"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21542748"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib7"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "The eXpeRience registry: the &#x201C;real&#x002D;world&#x201D; effectiveness of omalizumab in allergic asthma. Respir Med. 2013; 107:1141&#x002D;51."
                  "contribucion" => array:1 [
                    0 => array:3 [
                      "titulo" => "The eXpeRience registry&#58; the &#8220;real-world&#8221; effectiveness of omalizumab in allergic asthma&#46;"
                      "idioma" => "en"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "Braunstahl G-J"
                            1 => "Chen C-W"
                            2 => "Maykut R"
                            3 => "Georgiou P"
                            4 => "Peachey G"
                            5 => "Bruce J&#46;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.rmed.2013.04.017"
                      "Revista" => array:6 [
                        "tituloSerie" => "Respir Med. "
                        "fecha" => "2013"
                        "volumen" => "107"
                        "paginaInicial" => "1141"
                        "paginaFinal" => "1151"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23721684"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib8"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Does omalizumab make a difference to the real&#x002D;life treatment of asthma exacerbations?.: Results from a large cohort of patients with severe uncontrolled asthma. Chest. 2013; 143:398&#x002D;405."
                  "contribucion" => array:1 [
                    0 => array:3 [
                      "titulo" => "Does omalizumab make a difference to the real-life treatment of asthma exacerbations&#63;&#46;&#58; Results from a large cohort of patients with severe uncontrolled asthma&#46;"
                      "idioma" => "en"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:7 [
                            0 => "Grimaldi-Bensouda L"
                            1 => "Zureik M"
                            2 => "Aubier M"
                            3 => "Humbert M"
                            4 => "Levy J"
                            5 => "Benichou J"
                            6 => "et-al&#46;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Chest. "
                        "fecha" => "2013"
                        "volumen" => "143"
                        "paginaInicial" => "398"
                        "paginaFinal" => "405"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23505637"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib9"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "European Respiratory Society/American Thoracic Society Severe Asthma International Guidelines Task Force. From the authors: International European Respiratory Society/American Thoracic Society guidelines on severe asthma. Eur Respir J. 2014; 44:1378&#x002D;9."
                  "contribucion" => array:1 [
                    0 => array:3 [
                      "titulo" => "European Respiratory Society&#47;American Thoracic Society Severe Asthma International Guidelines Task Force&#46; From the authors&#58; International European Respiratory Society&#47;American Thoracic Society guidelines on severe asthma&#46;"
                      "idioma" => "en"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "Chung KF"
                            1 => "Wenzel S&#46;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1183/09031936.00120714"
                      "Revista" => array:6 [
                        "tituloSerie" => "Eur Respir J. "
                        "fecha" => "2014"
                        "volumen" => "44"
                        "paginaInicial" => "1378"
                        "paginaFinal" => "1379"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25362128"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib10"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "A proof&#x002D;of&#x002D;concept, randomized, controlled trial of omalizumab in patients with severe, difficult&#x002D;to&#x002D;control, nonatopic asthma. Chest. 2013; 144:411&#x002D;9."
                  "contribucion" => array:1 [
                    0 => array:3 [
                      "titulo" => "A proof-of-concept&#44; randomized&#44; controlled trial of omalizumab in patients with severe&#44; difficult-to-control&#44; nonatopic asthma&#46;"
                      "idioma" => "en"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:7 [
                            0 => "Garcia G"
                            1 => "Magnan A"
                            2 => "Chiron R"
                            3 => "Contin-Bordes C"
                            4 => "Berger P"
                            5 => "Taill&#233; C"
                            6 => "et-al&#46;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1378/chest.12-1961"
                      "Revista" => array:6 [
                        "tituloSerie" => "Chest. "
                        "fecha" => "2013"
                        "volumen" => "144"
                        "paginaInicial" => "411"
                        "paginaFinal" => "419"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23579324"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/08732159/0000002100000003/v0_201604141146/X0873215915188377/v0_201604141146/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "18132"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Editoriais"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/08732159/0000002100000003/v0_201604141146/X0873215915188377/v0_201604141146/en/320v21n03a90418837pdf001.pdf?idApp=UINPBA00004E&text.app=https://journalpulmonology.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0873215915188377?idApp=UINPBA00004E"
]
Share
Journal Information

Statistics

Follow this link to access the full text of the article

Omalizumab: a treatment for severe asthma in real life?
Anaïs Briqueta, Pascal Chaneza,
Corresponding author
pascal.chanez@univ-amu.fr

Corresponding author. pascal.chanez@univ-amu.fr
a Département des Maladies Respiratoires, AP-HM, INSERM CNRS U 1067, UMR7733, Aix Marseille Université, Marseille, France
Read
7284
Times
was read the article
2613
Total PDF
4671
Total HTML
Share statistics
 array:21 [
  "pii" => "X0873215915188377"
  "issn" => "08732159"
  "doi" => "10.1016/j.rppnen.2015.04.002"
  "estado" => "S300"
  "fechaPublicacion" => "2015-05-01"
  "documento" => "article"
  "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
  "subdocumento" => "fla"
  "cita" => "Rev Port Pneumol. 2015;21:111-2"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 3995
    "formatos" => array:3 [
      "EPUB" => 236
      "HTML" => 2654
      "PDF" => 1105
    ]
  ]
  "itemSiguiente" => array:16 [
    "pii" => "X0873215915188385"
    "issn" => "08732159"
    "doi" => "10.1016/j.rppnen.2014.09.009"
    "estado" => "S300"
    "fechaPublicacion" => "2015-05-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Rev Port Pneumol. 2015;21:113-25"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 5455
      "formatos" => array:3 [
        "EPUB" => 224
        "HTML" => 4239
        "PDF" => 992
      ]
    ]
    "en" => array:11 [
      "idiomaDefecto" => true
      "titulo" => "Lung adenocarcinoma&#58; Sustained subtyping with immunohistochemistry and EGFR&#44; HER2 and KRAS mutational status"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "113"
          "paginaFinal" => "125"
        ]
      ]
      "contieneResumen" => array:1 [
        "en" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig1"
          "etiqueta" => "Figure 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "copyright" => "Elsevier Espa&#241;a"
          "descripcion" => array:1 [
            "en" => "Case 21&#58; 2&#43; CK20 expression&#59; acinar pattern&#46; 200&#215;&#46;"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Vitor Sousa, Carolina Rodrigues, Maria Silva, Ana Maria Alarc&#227;o, Lina Carvalho"
          "autores" => array:5 [
            0 => array:2 [
              "nombre" => "Vitor"
              "apellidos" => "Sousa"
            ]
            1 => array:2 [
              "nombre" => "Carolina"
              "apellidos" => "Rodrigues"
            ]
            2 => array:2 [
              "nombre" => "Maria"
              "apellidos" => "Silva"
            ]
            3 => array:2 [
              "nombre" => "Ana Maria"
              "apellidos" => "Alarc&#227;o"
            ]
            4 => array:2 [
              "nombre" => "Lina"
              "apellidos" => "Carvalho"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0873215915188385?idApp=UINPBA00004E"
    "url" => "/08732159/0000002100000003/v0_201604141146/X0873215915188385/v0_201604141146/en/main.assets"
  ]
  "itemAnterior" => array:16 [
    "pii" => "X0873215915188369"
    "issn" => "08732159"
    "doi" => "10.1016/j.rppnen.2015.04.001"
    "estado" => "S300"
    "fechaPublicacion" => "2015-05-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Rev Port Pneumol. 2015;21:109-10"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 3162
      "formatos" => array:3 [
        "EPUB" => 238
        "HTML" => 1987
        "PDF" => 937
      ]
    ]
    "en" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "Routine characterization of biomarkers in non-small cell lung carcinoma&#58; how much is enough&#63;"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "109"
          "paginaFinal" => "110"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Jos&#233; Carlos Machado"
          "autores" => array:1 [
            0 => array:2 [
              "nombre" => "Jos&#233; Carlos"
              "apellidos" => "Machado"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0873215915188369?idApp=UINPBA00004E"
    "url" => "/08732159/0000002100000003/v0_201604141146/X0873215915188369/v0_201604141146/en/main.assets"
  ]
  "asociados" => array:1 [
    0 => array:18 [
      "pii" => "S2173511515000226"
      "issn" => "21735115"
      "doi" => "10.1016/j.rppnen.2014.07.004"
      "estado" => "S300"
      "fechaPublicacion" => "2015-05-01"
      "aid" => "1026"
      "copyright" => "Sociedade Portuguesa de Pneumologia"
      "documento" => "article"
      "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
      "subdocumento" => "sco"
      "cita" => "Rev Port Pneumol. 2015;21:151-6"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 1935
        "formatos" => array:3 [
          "EPUB" => 253
          "HTML" => 1166
          "PDF" => 516
        ]
      ]
      "en" => array:12 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Brief Communication</span>"
        "titulo" => "Real-life efficacy and safety of omalizumab in Portuguese patients with persistent uncontrolled asthma"
        "tienePdf" => "en"
        "tieneTextoCompleto" => "en"
        "tieneResumen" => "en"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "151"
            "paginaFinal" => "156"
          ]
        ]
        "contieneResumen" => array:1 [
          "en" => true
        ]
        "contieneTextoCompleto" => array:1 [
          "en" => true
        ]
        "contienePdf" => array:1 [
          "en" => true
        ]
        "resumenGrafico" => array:2 [
          "original" => 0
          "multimedia" => array:7 [
            "identificador" => "fig0005"
            "etiqueta" => "Figure 1"
            "tipo" => "MULTIMEDIAFIGURA"
            "mostrarFloat" => true
            "mostrarDisplay" => false
            "figura" => array:1 [
              0 => array:4 [
                "imagen" => "gr1.jpeg"
                "Alto" => 1765
                "Ancho" => 1667
                "Tamanyo" => 166595
              ]
            ]
            "descripcion" => array:1 [
              "en" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Analysis over the 24 months of treatment period&#46; &#40;a&#41; Effect on asthma control as measured by investigator assessment&#59; &#40;b&#41; effect on reduction in corticosteroid requirement&#46; Values are for the week before specified time points&#46;</p>"
            ]
          ]
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "M&#46; Pereira Barbosa, A&#46; Bugalho de Almeida, C&#46; Pereira, C&#46;-W&#46; Chen, P&#46; Georgiou, G&#46; Peachey"
            "autores" => array:7 [
              0 => array:2 [
                "nombre" => "M&#46;"
                "apellidos" => "Pereira Barbosa"
              ]
              1 => array:2 [
                "nombre" => "A&#46;"
                "apellidos" => "Bugalho de Almeida"
              ]
              2 => array:2 [
                "nombre" => "C&#46;"
                "apellidos" => "Pereira"
              ]
              3 => array:2 [
                "nombre" => "C&#46;-W&#46;"
                "apellidos" => "Chen"
              ]
              4 => array:2 [
                "nombre" => "P&#46;"
                "apellidos" => "Georgiou"
              ]
              5 => array:2 [
                "nombre" => "G&#46;"
                "apellidos" => "Peachey"
              ]
              6 => array:1 [
                "colaborador" => "on behalf of eXpeRience study group"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "en"
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173511515000226?idApp=UINPBA00004E"
      "url" => "/21735115/0000002100000003/v2_201505070217/S2173511515000226/v2_201505070217/en/main.assets"
    ]
  ]
  "en" => array:9 [
    "idiomaDefecto" => true
    "titulo" => "Omalizumab&#58; a treatment for severe asthma in real life&#63;"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "111"
        "paginaFinal" => "112"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Ana&#239;s Briquet, Pascal Chanez"
        "autores" => array:2 [
          0 => array:3 [
            "nombre" => "Ana&#239;s"
            "apellidos" => "Briquet"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "affa"
              ]
            ]
          ]
          1 => array:4 [
            "nombre" => "Pascal"
            "apellidos" => "Chanez"
            "email" => array:1 [
              0 => "pascal&#46;chanez&#64;univ-amu&#46;fr"
            ]
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "affa"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor1"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:3 [
            "entidad" => "Département des Maladies Respiratoires, AP&#x002D;HM, INSERM CNRS U 1067, UMR7733, Aix Marseille Université, Marseille, France"
            "etiqueta" => "<span class="elsevierStyleSup">a</span>"
            "identificador" => "affa"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor1"
            "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
            "correspondencia" => "Corresponding author. pascal.chanez@univ-amu.fr"
          ]
        ]
      ]
    ]
    "textoCompleto" => "<p class="elsevierStylePara">In 2015&#44; asthma remains an important health problem&#46; It is costly&#58; first as a chronic disorder it represents a significant burden for the patients and their relatives&#59; secondly due to management of disease including controller medications and what is required for acute exacerbations i&#46;e&#46;&#58; hospitalizations and days off work Overall&#44; while mortality has certainly decreased&#44; most of our current treatments are still primarily symptom based and do not alter with the natural history of the disease&#46; Meanwhile&#44; severe asthma remains a challenge&#44; as most patients with this type of asthma remain uncontrolled despite a real diagnosis&#44; a fair compliance and an important need of existing therapies with known side effects&#46;</p><p class="elsevierStylePara">Total IgE has been linked to asthma in epidemiological studies and was considered to be associated with an allergic phenotype of the disease&#46; More recently&#44; it has been shown to be a part of the high TH2 group of potential biomarkers&#44; such as eNO and blood eosinophils&#44; in predecting future risk including recurrent exacerbations&#46; IgE and IgE receptors play a part in the pathophysiology of asthma by activating various effector cells even in non- allergic situations&#46; Very recently an epigenome association with total IgE was reported&#44; and methylated genes encoding for eosinophil products were connected in a reproducible way&#46; The results were confirmed by isolated eosinophils from patients with high eosinophilia and asthma&#46; This type of study will certainly point towards new types of mechanisms&#44; which will allow a more personalized way to treat asthma&#46;<a href="&#35;bib1" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">1</span></a></p><p class="elsevierStylePara">Omalizumab has been shown in several well-performed studies to decrease the exacerbation rate in severe uncontrolled allergic asthma&#46;<a href="&#35;bib2" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">2</span></a> It has been used with success to treat mild asthma and allergic rhinitis and to prevent seasonal exacerbations in patients with a broad range of severity&#46;<a href="&#35;bib3" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">3</span></a> Randomized control studies are helpful to demonstrate the efficacy and safety of new drugs&#46; They are the bottom line of marketing in westernized countries&#46; They sustain the different guidelines&#44; but even though most of the recommendations are based on randomized control studies&#44; most of the patients with severe asthma are not qualified to enter RCP studies&#46;<a href="&#35;bib4" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">4</span></a> Therefore large pragmatic trials with real life conditions are currently more popular&#46; These trials will try to demonstrate efficiency and include a large numbers of patients&#46; They will enroll patients with less strict criteria&#44; closer a real clinical situation and allow a longitudinal follow-up with pertinent outcomes&#46;<a href="&#35;bib5" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">5</span></a><span class="elsevierStyleSup">&#44; </span><a href="&#35;bib6" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">6</span></a></p><p class="elsevierStylePara">In this issue of the journal&#44; taking advantage of the EXperience study&#44;<a href="&#35;bib7" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">7</span></a> our Portuguese colleagues have considered 62 patients from their own country to demonstrate an overall 60&#37; satisfaction with the treatment&#44; with a fair control of asthma including daily symptoms and exacerbations&#46; The treatment improves health related quality of life but has little impact on lung function&#46; This study describes an interesting observation and confirms the larger study from Grimaldi Bensoussa et al&#44; reporting the real improvement seen in the initial Innovate study&#46;<a href="&#35;bib8" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">8</span></a> The number of severe exacerbations and the need for oral corticosteroid upsurges were significantly decreased in this real life study of omalizumab treated patients as compared to the reference arm&#46; We can postulate that omalizumab is a well-established treatment in Europe for severe asthma&#46; It is advocated by the GINA guidelines and the ATS&#47;ERS task force on severe asthma&#44; however as a specific biotherapy it requires more investigation&#46;<a href="&#35;bib9" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">9</span></a> It would be worth knowing if we can confirm its efficacy in non-allergic severe asthma&#46;<a href="&#35;bib10" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">10</span></a> We are all fighting to improve antecipation of the response to the intervention&#46; At present&#44; we need specific biomarkers with an impact on future risk&#46; Last of all&#44; it is important to assess the potential for these interventions to go along with asthma remission&#44; but recent studies are not very encouraging&#46; Omalizumab is the first efficient and safe biotherapy for severe asthma with the potential to be used in this disease&#46; We should continue to question how it works and to report efficiency data from large real life cohort studies&#46;</p><p class="elsevierStylePara">Corresponding author&#46; pascal&#46;chanez&#64;univ-amu&#46;fr</p>"
    "pdfFichero" => "320v21n03a90418837pdf001.pdf"
    "tienePdf" => true
    "bibliografia" => array:2 [
      "titulo" => "Bibliography"
      "seccion" => array:1 [
        0 => array:1 [
          "bibliografiaReferencia" => array:10 [
            0 => array:3 [
              "identificador" => "bib1"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "An epigenome&#x002D;wide association study of total serum immunoglobulin E concentration. Nature. 2015. Feb 18. doi: 10.1038/nature14125. [Epub ahead of print]"
                  "contribucion" => array:1 [
                    0 => array:3 [
                      "titulo" => "An epigenome-wide association study of total serum immunoglobulin E concentration&#46;"
                      "idioma" => "en"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:7 [
                            0 => "Liang L"
                            1 => "Willis-Owen SAG"
                            2 => "Laprise C"
                            3 => "Wong KCC"
                            4 => "Davies GA"
                            5 => "Hudson TJ"
                            6 => "et-al&#46;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:2 [
                        "tituloSerie" => "Nature. "
                        "fecha" => "2015"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib2"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Omalizumab in asthma: an update on recent developments. J Allergy Clin Immunol Pract. 2014; 2:525&#x002D;36. e1"
                  "contribucion" => array:1 [
                    0 => array:3 [
                      "titulo" => "Omalizumab in asthma&#58; an update on recent developments&#46;"
                      "idioma" => "en"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:7 [
                            0 => "Humbert M"
                            1 => "Busse W"
                            2 => "Hanania NA"
                            3 => "Lowe PJ"
                            4 => "Canvin J"
                            5 => "Erpenbeck VJ"
                            6 => "et-al&#46;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jaip.2014.03.010"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Allergy Clin Immunol Pract. "
                        "fecha" => "2014"
                        "volumen" => "2"
                        "paginaInicial" => "525"
                        "paginaFinal" => "536"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25213045"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib3"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Randomized Trial of Omalizumab (Anti&#x002D;IgE) for Asthma in Inner&#x002D;City Children. N Engl J Med. 2011; 364:1005&#x002D;15."
                  "contribucion" => array:1 [
                    0 => array:3 [
                      "titulo" => "Randomized Trial of Omalizumab &#40;Anti-IgE&#41; for Asthma in Inner-City Children&#46;"
                      "idioma" => "en"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:7 [
                            0 => "Busse WW"
                            1 => "Morgan WJ"
                            2 => "Gergen PJ"
                            3 => "Mitchell HE"
                            4 => "Gern JE"
                            5 => "Liu AH"
                            6 => "et-al&#46;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMoa1009705"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med. "
                        "fecha" => "2011"
                        "volumen" => "364"
                        "paginaInicial" => "1005"
                        "paginaFinal" => "1015"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21410369"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib4"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "External Validity of Randomized Controlled Trials in Severe Asthma. AJRCCM. 2015. in press."
                  "contribucion" => array:1 [
                    0 => array:3 [
                      "titulo" => "External Validity of Randomized Controlled Trials in Severe Asthma&#46;"
                      "idioma" => "en"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "Pahus L"
                            1 => "Alagha K"
                            2 => "Sofalvi T"
                            3 => "et-al&#46;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:2 [
                        "tituloSerie" => "AJRCCM. "
                        "fecha" => "2015"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib5"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Can randomised trials inform clinical decisions about individual patients?. Lancet. 1999; 353:743&#x002D;6."
                  "contribucion" => array:1 [
                    0 => array:3 [
                      "titulo" => "Can randomised trials inform clinical decisions about individual patients&#63;&#46;"
                      "idioma" => "en"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "Mant D&#46;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S0140-6736(98)09102-8"
                      "Revista" => array:6 [
                        "tituloSerie" => "Lancet. "
                        "fecha" => "1999"
                        "volumen" => "353"
                        "paginaInicial" => "743"
                        "paginaFinal" => "746"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10073531"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib6"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Asthma treatment guidelines meet the real world. N Engl J Med. 2011; 364:1769&#x002D;70."
                  "contribucion" => array:1 [
                    0 => array:3 [
                      "titulo" => "Asthma treatment guidelines meet the real world&#46;"
                      "idioma" => "en"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "Dahl&#233;n S-E"
                            1 => "Dahl&#233;n B"
                            2 => "Drazen JM&#46;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMe1100937"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med. "
                        "fecha" => "2011"
                        "volumen" => "364"
                        "paginaInicial" => "1769"
                        "paginaFinal" => "1770"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21542748"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib7"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "The eXpeRience registry: the &#x201C;real&#x002D;world&#x201D; effectiveness of omalizumab in allergic asthma. Respir Med. 2013; 107:1141&#x002D;51."
                  "contribucion" => array:1 [
                    0 => array:3 [
                      "titulo" => "The eXpeRience registry&#58; the &#8220;real-world&#8221; effectiveness of omalizumab in allergic asthma&#46;"
                      "idioma" => "en"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "Braunstahl G-J"
                            1 => "Chen C-W"
                            2 => "Maykut R"
                            3 => "Georgiou P"
                            4 => "Peachey G"
                            5 => "Bruce J&#46;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.rmed.2013.04.017"
                      "Revista" => array:6 [
                        "tituloSerie" => "Respir Med. "
                        "fecha" => "2013"
                        "volumen" => "107"
                        "paginaInicial" => "1141"
                        "paginaFinal" => "1151"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23721684"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib8"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Does omalizumab make a difference to the real&#x002D;life treatment of asthma exacerbations?.: Results from a large cohort of patients with severe uncontrolled asthma. Chest. 2013; 143:398&#x002D;405."
                  "contribucion" => array:1 [
                    0 => array:3 [
                      "titulo" => "Does omalizumab make a difference to the real-life treatment of asthma exacerbations&#63;&#46;&#58; Results from a large cohort of patients with severe uncontrolled asthma&#46;"
                      "idioma" => "en"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:7 [
                            0 => "Grimaldi-Bensouda L"
                            1 => "Zureik M"
                            2 => "Aubier M"
                            3 => "Humbert M"
                            4 => "Levy J"
                            5 => "Benichou J"
                            6 => "et-al&#46;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Chest. "
                        "fecha" => "2013"
                        "volumen" => "143"
                        "paginaInicial" => "398"
                        "paginaFinal" => "405"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23505637"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib9"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "European Respiratory Society/American Thoracic Society Severe Asthma International Guidelines Task Force. From the authors: International European Respiratory Society/American Thoracic Society guidelines on severe asthma. Eur Respir J. 2014; 44:1378&#x002D;9."
                  "contribucion" => array:1 [
                    0 => array:3 [
                      "titulo" => "European Respiratory Society&#47;American Thoracic Society Severe Asthma International Guidelines Task Force&#46; From the authors&#58; International European Respiratory Society&#47;American Thoracic Society guidelines on severe asthma&#46;"
                      "idioma" => "en"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "Chung KF"
                            1 => "Wenzel S&#46;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1183/09031936.00120714"
                      "Revista" => array:6 [
                        "tituloSerie" => "Eur Respir J. "
                        "fecha" => "2014"
                        "volumen" => "44"
                        "paginaInicial" => "1378"
                        "paginaFinal" => "1379"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25362128"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib10"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "A proof&#x002D;of&#x002D;concept, randomized, controlled trial of omalizumab in patients with severe, difficult&#x002D;to&#x002D;control, nonatopic asthma. Chest. 2013; 144:411&#x002D;9."
                  "contribucion" => array:1 [
                    0 => array:3 [
                      "titulo" => "A proof-of-concept&#44; randomized&#44; controlled trial of omalizumab in patients with severe&#44; difficult-to-control&#44; nonatopic asthma&#46;"
                      "idioma" => "en"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:7 [
                            0 => "Garcia G"
                            1 => "Magnan A"
                            2 => "Chiron R"
                            3 => "Contin-Bordes C"
                            4 => "Berger P"
                            5 => "Taill&#233; C"
                            6 => "et-al&#46;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1378/chest.12-1961"
                      "Revista" => array:6 [
                        "tituloSerie" => "Chest. "
                        "fecha" => "2013"
                        "volumen" => "144"
                        "paginaInicial" => "411"
                        "paginaFinal" => "419"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23579324"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/08732159/0000002100000003/v0_201604141146/X0873215915188377/v0_201604141146/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "18132"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Editoriais"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/08732159/0000002100000003/v0_201604141146/X0873215915188377/v0_201604141146/en/320v21n03a90418837pdf001.pdf?idApp=UINPBA00004E&text.app=https://journalpulmonology.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0873215915188377?idApp=UINPBA00004E"
]
Article information
ISSN: 08732159
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 9 9 18
2024 October 37 32 69
2024 September 27 21 48
2024 August 47 36 83
2024 July 42 33 75
2024 June 52 18 70
2024 May 46 37 83
2024 April 41 36 77
2024 March 30 24 54
2024 February 35 25 60
2024 January 22 24 46
2023 December 25 23 48
2023 November 27 32 59
2023 October 25 39 64
2023 September 25 28 53
2023 August 20 17 37
2023 July 28 24 52
2023 June 16 18 34
2023 May 44 28 72
2023 April 29 22 51
2023 March 66 19 85
2023 February 46 27 73
2023 January 19 18 37
2022 December 37 17 54
2022 November 49 38 87
2022 October 47 31 78
2022 September 21 29 50
2022 August 33 38 71
2022 July 28 46 74
2022 June 18 33 51
2022 May 28 38 66
2022 April 19 30 49
2022 March 28 46 74
2022 February 25 41 66
2022 January 26 33 59
2021 December 22 36 58
2021 November 26 31 57
2021 October 36 47 83
2021 September 23 28 51
2021 August 22 20 42
2021 July 25 20 45
2021 June 14 24 38
2021 May 26 29 55
2021 April 63 58 121
2021 March 49 20 69
2021 February 50 13 63
2021 January 24 11 35
2020 December 16 6 22
2020 November 35 17 52
2020 October 30 12 42
2020 September 46 22 68
2020 August 57 24 81
2020 July 80 21 101
2020 June 63 15 78
2020 May 68 16 84
2020 April 52 10 62
2020 March 50 14 64
2020 February 52 23 75
2020 January 69 21 90
2019 December 60 24 84
2019 November 62 21 83
2019 October 73 24 97
2019 September 54 14 68
2019 August 109 19 128
2019 July 97 13 110
2019 June 110 19 129
2019 May 107 16 123
2019 April 106 22 128
2019 March 93 10 103
2019 February 108 11 119
2019 January 108 24 132
2018 December 50 7 57
2018 November 13 0 13
2018 October 22 10 32
2018 September 18 9 27
2018 August 31 25 56
2018 July 33 24 57
2018 June 38 22 60
2018 May 54 20 74
2018 April 68 20 88
2018 March 57 16 73
2018 February 26 11 37
2018 January 12 13 25
2017 December 48 18 66
2017 November 18 24 42
2017 October 22 13 35
2017 September 18 19 37
2017 August 22 15 37
2017 July 16 11 27
2017 June 30 20 50
2017 May 27 17 44
2017 April 13 8 21
2017 March 12 8 20
2017 February 9 4 13
2017 January 14 9 23
2016 December 15 10 25
2016 November 6 5 11
2016 October 8 6 14
2016 September 2 0 2
2016 August 2 3 5
2016 July 3 8 11
2016 June 0 5 5
2016 May 0 4 4
2016 April 29 2 31
2016 March 46 31 77
2016 February 51 31 82
2016 January 39 28 67
2015 December 49 26 75
2015 November 32 21 53
2015 October 44 36 80
2015 September 47 43 90
2015 August 59 42 101
2015 July 65 33 98
2015 June 86 46 132
2015 May 215 125 340
Show all

Follow this link to access the full text of the article

Pulmonology

Are you a health professional able to prescribe or dispense drugs?